摘要
目的:比较麝香保心丸与复方丹参滴丸治疗冠状动脉粥样硬化性心脏病(冠心病)心绞痛的临床疗效。方法:冠心病心绞痛患者60例,其中30例(治疗组)采用麝香保心丸口服治疗,并与用复方丹参滴丸治疗的30例(对照组)做疗效比较,两组疗程均为4周。结果:治疗组心绞痛及心电图的总有效率分别为90.6%和71.9%,均显著高于对照组(53.1%和43.8%,P<0.01);治疗组在减少心绞痛发作次数、持续时间及硝酸甘油用量、改善心肌缺血的范围和程度、降低心悸耗氧量等方面亦显著优于对照组(P<0.05或P<0.01)。结论:麝香保心丸治疗冠心病心绞痛疗效显著,优于复方丹参滴丸。
Objective： To compare the clinical efficacy of Shexiang Baoxin pill and compound Danshen dripping pill in treatment of angina pectoris of coronary heart disease. Methods： 60 patients with angina pectoris of coronary heart disease were selected, 30 cases （treatment group） were treated with oral administration of Shexiang Baoxin pill, and 30 cases （control group） were treated with Compound Danshen Dripping Pills （control group）, the clinical efficacy was compared. The treatment course of two groups was 4 weeks. Results： The total efficiency of angina and ECG of the treatment group was 90.6% and 71.9% respectively, which was significantly higher than that of the control group, 53.1% and 43.8% respectively, P 〈 0.01; in reducing angina attack frequency, lasting time and dosage of nitroglycerin and improving the range and degree of myocardial ischemia, reducing low heart oxygen consumption, the improvement of the treatment group was also significantly better than that of the control group （P 〈 0.05 or P 〈 0.01）. Conclusion： The curative effect of Shexiang Baoxin pill was significant in the treatment of angina pectoris of coronary heart disease and its effect was better than that of Compound Danshen dripping pill.
出处
《中医临床研究》
2016年第30期30-31,共2页
Clinical Journal Of Chinese Medicine
关键词
麝香保心丸
复方丹参滴丸
心脏病
冠状动脉粥样硬化性
心绞痛
Shexiang Baoxin pill
Compound Danshen dripping pill
Heart disease
Coronary artery disease
Angina pectoris
